Nina Patel
Company: Boehringer Ingelheim
Job title: Director – Clinical Development & Medical Affairs ILD
Seminars:
Understanding How to Define Patient Populations, Select Optimal Intervention Points & Outline Clear Therapeutic Outcomes to Streamline the Design & Development of Therapies for Inflammatory ILDs 9:30 am
Utilizing clinical parameters versus radiographic parameters to define patient subgroups Clinical versus physiologic versus radiologic parameters to determine timing of intervention Choosing clinical trial outcomes in a heterogeneous trial populationRead more
day: Day 1